Our Clinical Research Center (CRC) staff conduct Phase I-II and Phase III-IV outpatient studies involving investigational and marketed drugs and biologics.

Our research programs are open to patients interested in gaining access to new medical treatments or participating in comparative studies of available medications. In some cases, the clinical research programs provide therapies that are not available to the general public. Patients involved in our study programs receive special attention from our clinical research team, which includes physicians, research nurses, nutritionists and an exercise physiologist.

We have considerable experience in the development of research protocols for new medications. Our organization has been recognized by the pharmaceuticals industry and government agencies for the quality of the care we provide and our excellent track record in attracting patients to studies. The physician investigators and staff at the BIOCANCER Center for Clinical Research are committed to forging partnerships with patients and sponsors for the advancement of clinical medicine.

The CRC is staffed with study coordinators who hold degrees in medicine, nursing and related health areas, as well as principal investigators and clinical pharmacists, all of whom are experienced in conducting Phase I-IV clinical studies.

Our clinical research facility is equipped to house research subjects for extended day and overnight evaluations. All the study protocols are supervised by the principal investigator in close collaboration with the study coordinators. Inpatient and outpatient study populations are carefully selected for clinical trials according to the sponsor's specifications.

BIOCANCER maintains a large computerized database of healthy volunteers and patients, which means we can quickly meet any enrolment needs. The CRC staff are also skilled in recording sponsor data, whether on case report forms or in remote data entry applications.